Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into standard-of-care first-line treatment for patients with epithelioid malignant pleural mesothelioma—Protocol of the Immuno-MESODEC study

Source
PLoS ONE - ISSN 1932-6203-19:7 (2024) p. 1-15
Author(s)

Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma : protocol of a monocentric phase I/II clinical trial in Belgium

Source
BMJ open - ISSN 2044-6055-14:3 (2024) p. 1-10
Author(s)

Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS) : a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration

Source
BMJ open - ISSN 2044-6055-9:9 (2019) p. 1-11
Author(s)
    Barbara Willekens, Silvia Presas-Rodriguez, M. J. Mansilla, Judith Derdelinckx, Wai Ping Lee, Griet Nijs, Maxime De Laere, Inez Wens, Patrick Cras, Paul M. Parizel, Wim Van Hecke, Annemie Ribbens, Thibo Billiet, Geert Adams, Marie Madeleine Couttenye, Juan Navarro-Barriuso, Aina Teniente-Serra, Bibiana Quirant-Sanchez, Ascension Lopez-Diaz de Cerio, Susana Inoges, Felipe Prosper, Anke Kip, Herman Verheij, Catharina C. Gross, Heinz Wiendl, Marieke (SM) Van Ham, Anja Ten Brinke, Ana Maria Barriocanal, Anna Massuet-Vilamajo, Niel Hens, Zwi Nisan Berneman, Eva Martinez-Caceres, Nathalie Cools, Cristina Ramo-Tello, Naomi Ooms, Dirk Smeets, Leone Bock, Denis Groot, Wim-Jan Koot, Janwillem Boiten, Jorg Janssen, Sjaak Peelen, A. Turksma, R. Vanlier, T. Rispens, D. DiBlasi, Iris Claessen, M. Puig-Domingo, Laia Lagunas Vila, Jana Arnholdt

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Source
Blood - ISSN 0006-4971-130:15 (2017) p. 1713-1721
Author(s)